Comparison

polygalaxanthone III European Partner

Item no. TMO-T3696-200mg
Manufacturer TargetMol
CASRN 162857-78-5
Amount 200 mg
Quantity options 100 mg 100 mg 10 mg 10 mg 1 mg 200 mg 25 mg 25 mg 2 mg 2 mg 50 mg 50 mg 5 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9974
Citations 1. Lv C, et al. J Sep Sci. 2014 May;37(9-10):1103-10.
Smiles COc1cc2c(cc1O)oc1cc(O)c([C@@H]3O[C@H](CO[C@@H]4OC[C@](O)(CO)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(O)c1c2=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cytochromes P450
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
568, 48
Description
Polygalaxanthone III can significantly inhibit chlorzoxazone 6-hydroxylation catalyzed by CYP2E1.
Pathways
Metabolism
Bioactivity
Polygalaxanthone III can significantly inhibit chlorzoxazone 6-hydroxylation catalyzed by CYP2E1.
Receptor
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close